43 results on '"Märtson, Anne-Grete"'
Search Results
2. Exposure of anti-infective drugs and the dynamic changes of the gut microbiota during gastrointestinal mucositis in autologous stem cell transplant patients: a pilot study
3. Subtherapeutic exposure of ganciclovir in children despite appropriate dosing: a short communication
4. A snapshot of exhaled nitric oxide and asthma characteristics: experience from high to low income countries
5. Population Pharmacokinetics and Bayesian Dose Adjustment to Advance TDM of Anti-TB Drugs
6. Therapeutic Drug Monitoring in Non-Tuberculosis Mycobacteria Infections
7. Towards pharmacokinetic boosting of phenoxymethylpenicillin (penicillin-V) using probenecid for the treatment of bacterial infections.
8. Therapeutic Drug Monitoring of Ganciclovir: Where Are We?
9. Therapeutic Drug Monitoring of the Echinocandin Antifungal Agents: Is There a Role in Clinical Practice? A Position Statement of the Anti-Infective Drugs Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology
10. Therapeutic Drug Monitoring of Anti-infective Drugs: Implementation Strategies for 3 Different Scenarios
11. Antimicrobial treatment imprecision: an outcome-based model to close the data-to-action loop
12. Ganciclovir Therapeutic Drug Monitoring: A Case Series
13. Voriconazole exposure is influenced by inflammation: A population pharmacokinetic model
14. Standard ganciclovir dosing results in slow decline of cytomegalovirus viral loads
15. Population pharmacokinetics of liposomal amphotericin B in adults with HIV-associated cryptococcal meningoencephalitis
16. Shedding a Light on Acyclovir Pharmacodynamics: A Retrospective Analysis on Pharmacokinetic/Pharmacodynamic Modelling of Acyclovir for the Treatment of Varicella Zoster Virus Infection in Immunocompromised Patients: A Pilot Study
17. Optimised administration of anti-infective drugs for prophylaxis and treatment in immunocompromised patients
18. TDM of Anti-infective Drugs: Implementation Strategies for Three Different Scenarios
19. Subtherapeutic Exposure of Ganciclovir in Children Despite Appropriate Dosing: A Short Communication.
20. Mast Cells Differentiated in Synovial Fluid and Resident in Osteophytes Exalt the Inflammatory Pathology of Osteoarthritis
21. Precision Therapy for Invasive Fungal Diseases
22. Mast cells differentiated in synovial fluid and resident in osteophytes exalt the inflammatory pathology of osteoarthritis
23. Therapeutic Drug Monitoring of Ganciclovir: Where Are We?
24. Does Chemotherapy-Induced Gastrointestinal Mucositis Affect the Bioavailability and Efficacy of Anti-Infective Drugs?
25. Ganciclovir therapeutic drug monitoring in transplant recipients
26. Investigator-Initiated Studies in Infectious Diseases—Considerations for Pharmacokinetic-Pharmacodynamic Optimization
27. Caspofungin Weight-Based Dosing Supported by a Population Pharmacokinetic Model in Critically Ill Patients
28. Therapeutic drug monitoring in patients with tuberculosis and concurrent medical problems
29. Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid)
30. Caspofungin Weight-Based Dosing Supported by a Population Pharmacokinetic Model in Critically Ill Patients
31. Ethionamide Population Pharmacokinetic Model and Target Attainment in Multidrug-Resistant Tuberculosis
32. Epidemic and pandemic viral infections: impact on tuberculosis and the lung
33. Saliva for Precision Dosing of Antifungal Drugs: Saliva Population PK Model for Voriconazole Based on a Systematic Review.
34. Exploring failure of antimicrobial prophylaxis and pre-emptive therapy for transplant recipients: a systematic review
35. Posaconazole therapeutic drug monitoring in clinical practice and longitudinal analysis of the effect of routine laboratory measurements on posaconazole concentrations
36. Posaconazole trough concentrations are not influenced by inflammation: a prospective study
37. Posaconazole therapeutic drug monitoring in clinical practice and longitudinal analysis of the effect of routine laboratory measurements on posaconazole concentrations
38. Posaconazole trough concentrations are not influenced by inflammation: A prospective study
39. Determination of Ganciclovir and Acyclovir in Human Serum using Liquid Chromatography-Tandem Mass Spectrometry
40. From Therapeutic Drug Monitoring to Model‐Informed Precision Dosing for Antibiotics.
41. Therapeutic drug monitoring in patients with tuberculosis and concurrent medical problems
42. Precision Therapy for Invasive Fungal Diseases.
43. A systematic review of antibiotic drug shortages and the strategies employed for managing these shortages.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.